Molecular imaging biomarkers for immune checkpoint inhibitor therapy

Immune checkpoint inhibitors (ICIs) have substantially changed the field of oncology over the past few years. ICIs offer an alternative treatment strategy by exploiting the patients' immune system, resulting in a T cell mediated anti-tumor response. These therapies are effective in multiple dif...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Donk, Pim P, Kist de Ruijter, Laura, Lub-de Hooge, Marjolijn N, Brouwers, Adrienne H, van der Wekken, Anthonie J, Oosting, Sjoukje F, Fehrmann, Rudolf SN, de Groot, Derk Jan A, de Vries, Elisabeth GE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993216/
https://www.ncbi.nlm.nih.gov/pubmed/32042331
http://dx.doi.org/10.7150/thno.38339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993216/
https://www.ncbi.nlm.nih.gov/pubmed/32042331
http://dx.doi.org/10.7150/thno.38339

Ejemplares similares